Skip to main content
. Author manuscript; available in PMC: 2018 May 2.
Published in final edited form as: Int J Cancer. 2017 Apr 15;140(8):1727–1735. doi: 10.1002/ijc.30590

Table 1.

Baseline characteristics of cases with pancreatic cancer and control subjects1

Factor Controls (N=448) Cases (N=448) P-value2
Age at recruitment (years, mean ± SD) 57.8 ± 7.8 57.8 ± 7.8 matched
Sex, n (%) matched
Male 213 213
Female 235 235
Age at blood collection (±3 years) 58.0 ± 7.8 58.0 ± 7.8 matched
Fasting status, n (%) matched
Fasting (≥6 h) 104 (23.2) 112 (25.0)
In between (3–6 h) 69 (15.4) 68 (15.2)
Not-fasting (<3 h) 172 (38.4) 172 (38.4)
Unknown 103(23.0) 96 (21.4)
Height (cm, mean ± SD)
Male 175.1 ± 7.6 174.6 ± 7.3 0.68
Female 161.4 ± 7.0 162.2 ± 6.5 0.19
Weight (kg, mean ± SD)
Male 82.1 ± 12.6 81.7 ± 11.7 0.69
Female 65.6 ± 11.0 69.5 ± 13.3 0.0004
Waist to hip ratio (mean ± SD)
Male 0.95 ± 0.06 0.95 ± 0.06 0.62
Female 0.81 ± 0.06 0.81 ± 0.07 0.15
Smoking status (%)
Never 194 (43.3) 165 (36.8)
Former 153 (34.2) 140 (31.3)
Current 96 (21.4) 138 (30.8) 0.002
Unknown 5 5
History of diabetes mellitus (%)
No 409 (95.6) 397 (92.8)
Yes 19 (4.4) 31 (7.2) 0.09
Unknown 20 20
Pepsinogen I, n (%)
Low (<25) 14 (3.2) 20 (4.5)
High (≥25) 427 (96.8) 422 (95.5) 0.29
Missing 7 6
Pepsinogen I/II, n (%)
Low (<3) 25 (5.7) 28 (6.3)
High (>3) 416 (94.3) 414 (93.7) 0.66
Missing 7 6
H. pylori, n (%)
HP negative 241 (53.9) 250 (56.1)
HP positive 206 (46.1) 196 (44.0) 0.50
Missing 1 2
CagA, n (%)
CagA negative 306 (68.9) 302 (68.3)
CagA positive 138 (31.1) 140 (31.7) 0.88
Missing 4 6
1

Cases and control subjects were 1:1 matched on center, sex, age at blood collection (±3 years), date of blood donation (±3 months), time of blood donation (±2 h), and fasting status (<3h, 3–6h or >6 after the last meal).

2

P values were derived from paired t test for continuous variable, and from McNemar’s test or generalized McNemar’s test for categorical variables.